News > Indian-origin pharma boss banned for price-fixing in UK

Indian-origin pharma boss banned for price-fixing in UK

An Indian-origin pharmaceutical industry chief has signed undertakings that ban him from holding a director role at any UK company for the next five years, in connection with his role in companies that were allegedly involved in illegal arrangements such as price-fixing of drugs. Amit Patel, a former director at the pharmaceutical companies Auden McKenzie and Amilco, was the subject of a UK Competition and Markets Authority (CMA) investigation.